Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ruth

Ruth Bauer, Mannheim DE

Patent application numberDescriptionPublished
20080319109Solid Pigment Preparations Containing Resin - Solid pigment preparations comprising as essential components 12-25-2008

Ruth Beck Keissary, Haifa IL

Patent application numberDescriptionPublished
20110253910Electromagnetic Beams Power Combining - A method for combining power of separate directed energy beams each associated with a separate firing unit, on a common spot on target. The firing units are coordination and synchronization unit (FUSU) tracks a target and assigns a master firing unit and slave firing units. The master firing unit sends a guide beam to the target, forming a local coordinate system on said target, while the slave firing units track the target and track at least one spot of EM (electromagnetic) radiation on the target. The slave units calculate a direction vector, and fire a power beam at the target, together with the master unit.10-20-2011
20120026734OPTOMECHANICAL MEMS DEVICE - A micro-opto-electro-mechanical system having a proof mass; at least one illumination source for providing illumination; an illumination detector; peripheral electronics; and an illumination mitigating mechanism for mitigating the effect of illumination emitted from the at least one illumination source on the peripheral electronics. According to various embodiments, the illumination mitigating mechanism includes handles disposed on the proof mass, an illumination collimating device, a substrate with a recess, a narrow beam light source, an illumination absorbing layer or optical limiters.02-02-2012

Ruth Belostotsky, Maale Adumim IL

Patent application numberDescriptionPublished
20080255339Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities - The present invention relates to chimeric proteins with cell-targeting specificity and apoptosis-inducing activities. In particular, the invention is illustrated by examples of chimeric proteins including recombinant chimeric proteins between a gonadoptropin releasing hormone (GnRH) and an apoptosis-inducing moiety, such as a pro-apoptotic member of Bcl-2 family, such as Bik, Bax and Bak, or caspases, such as caspase-3. The chimeric proteins specifically target cells expressing a GnRH-binding site, such as adenocarcinoma cells, and induce cell-specific apoptosis.10-16-2008
20090317358CHIMERIC PROTEINS WITH CELL-TARGETING SPECIFICITY AND APOPTOSIS-INDUCING ACTIVITIES - The present invention relates to chimeric proteins with cell-targeting specificity and apoptosis-inducing activities. In particular, the invention is illustrated by a recombinant chimeric protein between human interleukin-2 (IL2) and Bax. The chimeric protein specifically targets IL2 receptor (IL2R)-expressing cells and induces cell-specific apoptosis.12-24-2009

Patent applications by Ruth Belostotsky, Maale Adumim IL

Ruth Birner-Grünberger, Hitzendorf AT

Patent application numberDescriptionPublished
20110224096FLUORESCENT PHOSPHONIC ESTER LIBRARY - An assay library comprising 14 fluorescently labeled phosphonate esters which act as serine hydrolase inhibitors is provided as an analytical tool enabling activity based identification of serine hydrolases and characterization of enzyme preparations, protein mixtures and complex proteome samples.09-15-2011

Ruth Brack-Werner, München DE

Patent application numberDescriptionPublished
20110294721ANTIMICROBIAL PEPTIDES - The present invention relates to a peptide comprising or consisting of a sequence of formula I A-B-C-D-E-F-G-H-I (formula I), wherein A is a peptide consisting of three or four basic amino acid residues; B is a peptide consisting of two to four hydrophobic amino acid residues; C is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; D is a peptide consisting of two hydrophobic amino acid residues; E is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; F is a peptide consisting of three amino acid residues selected from the group consisting of glycine and hydrophobic amino acid residues; G is an amino acid residue selected from the group consisting of hydrophobic and basic amino acid residues; H is a peptide consisting of two or three amino acid residues selected from the group consisting of serine and hydrophobic amino acid residues; I is a peptide consisting of two to four basic amino acid residues; or a peptidomimetic thereof, wherein the basic amino acid residues are selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residues are selected from the group consisting of leucine, alanine, isoleucine, valine and phenylalanine; and wherein said peptide or peptidomimetic has antimicrobial and/or antiviral activity. Furthermore, the invention relates to a nucleic acid molecule encoding the peptide of the invention, a vector comprising the nucleic acid molecule as well as a host cell comprising the nucleic acid molecule or the vector. The present invention also relates to a method for producing the peptide of the invention, a composition comprising the peptide or peptidomimetic of the invention as well as to the peptide or peptidomimetic of the invention for use in treating infectious diseases.12-01-2011
20120020940ANTIMICROBIAL PEPTIDES - The present invention relates to a peptide comprising or consisting of the following amino acid sequence: A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10-A11-A12 (formula II), wherein A0 is a hydrophobic amino acid residue or is absent; A1, A4, A7, A8, A12 each are a hydrophobic amino acid residue; and A2, A6, A9, A10 each are a basic amino acid residue; A5 is an alanine or a basic amino acid residue; A3, A11 each are a basic amino acid residue, or a hydrophobic amino acid residue; or a peptidomimetic thereof; wherein the basic amino acid residues are selected from the group consisting of arginine, lysine and histidine; wherein the hydrophobic amino acid residues are selected from the group consisting of leucine, alanine, isoleucine, valine, methionine and phenylalanine; and wherein said peptide or peptidomimetic has antimicrobial and/or antiviral activity. Furthermore, the invention relates to a nucleic acid molecule encoding the peptide of the invention, a vector comprising the nucleic acid molecule as well as a host cell comprising the nucleic acid molecule or the vector. The present invention also relates to a method for producing the peptide of the invention, a composition as well as to the peptide or peptidomimetic of the invention for use in treating infectious diseases.01-26-2012

Ruth Chiquet-Ehrismann, Reinach CH

Patent application numberDescriptionPublished
20100173314DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS - Tenascin-W. an extracellular matrix molecule that is specifically expressed in metastatic tumours is provided. A system comprising a sample expressing tenascin-W is used as an in vitro method for screening possible anti-tumour agents or for agents that promote osteogenesis.07-08-2010

Patent applications by Ruth Chiquet-Ehrismann, Reinach CH

Ruth Chiquet-Ehrismann, Prattein CH

Patent application numberDescriptionPublished
20110229494TENEURIN AND CANCER - The present invention relates to a method for treating cancer, for instance brain tumors, in a subject by inhibiting a teneurin by administering to said subject a therapeutically effective amount of a modulator of said teneurin, for example a specific antibody or a siRNA. The present invention also encompasses methods of diagnosing cancer by measuring levels of teneurin.09-22-2011

Ruth Cohen, Neveh Ephraim IL

Patent application numberDescriptionPublished
20100048728POLYCYCLIC DIANTHRAQUINONES AS INHIBITORS OF INFLAMMATORY CYTOKINES - The present invention relates to the therapeutic use of polycyclic dianthraquinones including hypericin, helianthrones and helianthrone derivatives as inhibitors of the proinflammatory cytokine cascade mediated inflammatory conditions such as inflammatory bowel disease and cachexia. In addition the compositions can be used for prevention of development of inflammation, fibrosis and vasculopathy as a sequelae induced by irradiation treatment, and to the use thereof, as protective modes for the consequences of irradiation treatment in diseases such as cancers. The present invention can also be used to prevent or improve the inflammatory consequences of infections with viruses or bacteria and to prevent or treat neuroinflammatory disorders.02-25-2010

Ruth Corcoran-Henry, Middlesex GB

Patent application numberDescriptionPublished
20110256074NOVEL USE - A oral care composition comprising a triple polymer system and a source of fluoride ions for combating (i.e. helping to prevent, inhibit and/or treat) dental erosion and/or tooth wear is described. Such compositions are also of use in combating dental caries.10-20-2011

Ruth Dammert, Stenungsund SE

Patent application numberDescriptionPublished
20080254289Scorch-Retarding Polymer Composition - The present invention relates to crosslinkable polymer composition, comprising an unsaturated polyolefin having a total amount of carbon-carbon double bonds/1000 carbon atoms of at least 0.1, at least one scorch retarder, and at least one crosslinking agent.10-16-2008

Ruth Gallily, Jerusalem IL

Patent application numberDescriptionPublished
20100099756USES OF INCENSOLE, INCENSOLE ACETATE AND DERIVATIVES THEREOF - The described subject matter relates to the use of incensole, incensole acetate, and derivatives thereof, for the treatment, prevention or amelioration of diseases or conditions, including inflammatory-associated conditions; a disease or condition where neuroprotection is required; and a disease or condition selected from depression, anxiety, obsessive compulsive behaviors, deterioration in cognitive function, and deterioration in neurobehavioral function. Pharmaceutical compositions and method of treatment, prevention or amelioration of the above-mentioned diseases or conditions are also provided.04-22-2010
20100158973THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS - The present invention provides the use of a Cannabidiol (CBD) compound for the preparation of a pharmaceutical composition for treatment as well as for the prevention of at least one fundamental parameter affecting a vascular system selected from (a) the cardiovascular system; (b) the peripheral vascular system; or (c) a combination of (a) and (b); as well as pharmaceutical compositions and therapeutic methods for treating the above. A fundamental parameter may include blood/plasma lipid profile; atherosclerosis plaque load; size of heart scar; thickness of heart scar; and cardiac function in general. In accordance with a preferred embodiment the invention concerns treatment of heart scars as well as preventing the formation of heart scars.06-24-2010

Ruth Golden-Morace, Arlington, TX US

Ruth Guptil, Taunton, MA US

Patent application numberDescriptionPublished
20090152272Removable Breathable Covers for Beverage Containers - Covers for containers and specifically, beverage containers are disclosed herein. According to one embodiment of the invention, a cover has a breathable membrane and a peripheral rim. The membrane is substantially planar in shape and has a length and width to substantially cover a top opening of a beverage container. A plurality of orifices extend through a top surface toward and through a bottom surface of the breathable membrane, and are sized and shaped to allow air to pass therethrough, but are sufficiently small to prevent external contaminants such as leaves and insects, for example, from passing through the membrane. The peripheral rim is sized and shaped to receive an upper portion of a rim of the container, and be releasably attached thereto. Thus, the cover provides means for enjoying beverages such as wines requiring breathing prior to consummation, carbonated drinks, and other beverage, in the outdoors.06-18-2009

Ruth Houbertz, Werneck-Schraudenbach DE

Patent application numberDescriptionPublished
20090252471CONDENSATION PRODUCTS OF SILICIC ACID DERIVATIVES AND OPTICAL WAVEGUIDE DEVICES USING THE SAME - The present invention relates to condensation products of silicic acid derivatives usable especially in optical waveguides and particularly to a condensation product obtained by condensing a silane diol compound (A) of the general formula (1): R10-08-2009

Ruth Houbertz-Krauss, Werneck DE

Patent application numberDescriptionPublished
20110017944Method for Encapsulating Latent Heat Storage Material and Products Obtained Thereby - The invention relates to a method for producing an inorganic latent heat storage material that is surrounded by an encapsulating layer that is made of an inorganic-organic polymer material that comprises a metal and/or semi-metal oxygen network with embedded organic groups. The method is characterised in that a liquid or liquefied latent heat storage material, in the form of discrete units that are to be, respectively, encapsulated, is introduced into a liquid or viscous precursor material of the encapsulating material such that the encapsulating material solidifies when coming into contact with the outer surfaces of said latent heat storage material. The invention also relates to an inorganic latent heat storage material that is surrounded by an encapsulating layer and is present in said encapsulation, said encapsulating material being made of an inorganic-organic polymer material that comprises a (semi) metal oxygen network with embedded organic groups, connected, preferably at least partially to (semi) metal. Silane resins are well suited as precursor material.01-27-2011

Ruth Iaconi-Forrer, Moehlin CH

Patent application numberDescriptionPublished
20080302688Container and Carrier System - The invention relates to a container (12-11-2008

Ruth Isabel Gomez, Segovia ES

Patent application numberDescriptionPublished
20080261090Catalyst for a Catalytic Process Which is Used to Obtain Hydrogen from Bioethanol and/or Ethanol, Catalyst-Preparation Method and Use Thereof in Said Catalytic Process - The invention relates to a catalyst which is used to obtain hydrogen or a hydrogen-rich gas that is suitable for use in fuel cells or other applications from bioethanol and/or ethanol, comprising a support, a promoter agent and an active phase which is incorporated into the support, said catalyst taking the form of a calcinated solid in which the support comprises at least one oxide with high surface mobility and is modified with the promoter agent. According to the invention, the promoter agent comprises at least one oxide of a rare earth that is selected from the lanthanide group and the active phase comprises at least one oxide of a transition metal from group VIII or IB.10-23-2008

Ruth Isserlin, Thornhill CA

Patent application numberDescriptionPublished
20100285491USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro comprising the steps of measuring in a sample the concentration of the marker IGFBP-7, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for IGFBP-7 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of IGFBP-7 as a marker protein in the assessment of heart failure, a marker combination comprising IGFBP-7 and a kit for measuring IGFBP-7.11-11-2010
20100285492USE OF SLIM-1 IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro comprising the steps of measuring in a sample the concentration of the marker SLIM-1, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SLIM-1 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SLIM-1 as a marker protein in the assessment of heart failure, a marker combination comprising SLIM-1 and a kit for measuring SLIM-1.11-11-2010

Ruth Jostock, Solberg DE

Patent application numberDescriptionPublished
20090186899Substituted Sulfonamide Compounds - Substituted sulfonamide compounds corresponding to the formula I07-23-2009
20090203672Substituted Sulfonamide Compounds - Substituted sulfonamide compounds corresponding to the formula I′08-13-2009

Ruth Kimmons, West Orange, NJ US

Patent application numberDescriptionPublished
20110094365BOW HOLD TRAINING DEVICE - Training devices for facilitating proper bow holds on bow sticks of bowed stringed instruments. An exemplary training device may include a fingers stabilizer having a body with one or more thumb opening walls that define a thumb opening in the body. The thumb opening walls and/or the thumb opening may guide a thumb to the bow stick and position an end of the thumb at an approximate intersection of a bow stick frog and a bow stick shaft. The body may also include a finger separator that helps position an index finger and a middle finger on the bow stick. The fingers stabilizer may also have contact areas for positioning a ring finger and a pinky finger on the bow stick.04-28-2011

Ruth Kluser, Bonn DE

Patent application numberDescriptionPublished
20090028783Gas/solid phase reaction - The invention relates to a process and reactor for the quasi-continuous performance of a chemical reaction on the surface of a fixed reactant in a gas/solid phase reaction. In particular, the invention relates to a thermal process and a reactor for the continuous preparation of hydrogen from water vapor on the surface of a metal oxide in a gas/solid phase reaction.01-29-2009

Ruth Kummerlen, College Station, TX US

Patent application numberDescriptionPublished
20090203329Patient Medication IV Delivery Pump with Wireless Communication to a Hospital Information Management System - A wireless communication system from an IV medication infusion pump to a hospital information management system (HIMS) is disclosed. The system includes an IV pump having pump operation circuitry for monitoring pre-selected characteristics of pump operation indicative of IV administration of medication to a patient. A transmitter or transceiver is connected to the pump operation circuitry for receiving a wireless pump signal representing instructional data to the IV pump and for transmitting a wireless pump signal representing the pre-selected pump operation characteristics. The wireless pump transmitter or transceiver communicates with a hospital information management system (HIMS). The HIMS includes a receiver or transceiver capable of transmitting and receiving the pump signal representing the pump operation characteristics and also includes a computer processor capable of storing and displaying the pump operation characteristics that are represented by the received wireless pump signal. In one embodiment, is a medication order transmitter capable of receiving doctor order input and transmitting a signal representing a pumping operation to the HIMS for comparison to pump operation characteristics represented by the pump signal.08-13-2009

Ruth KÜster, Bonn DE

Patent application numberDescriptionPublished
20110135566GAS/SOLID PHASE REACTION - The invention relates to a process and reactor for the quasi-continuous performance of a chemical reaction on the surface of a fixed reactant in a gas/solid phase reaction. In particular, the invention relates to a thermal process and a reactor for the continuous preparation of hydrogen from water vapor on the surface of a metal oxide in a gas/solid phase reaction.06-09-2011

Ruth Li, Shanghai CN

Patent application numberDescriptionPublished
20090327679OS-MEDIATED LAUNCH OF OS-INDEPENDENT APPLICATION - A system, method, and computer readable medium for an operating system (OS) mediated launch of an OS dependent application is disclosed. An application running within an OS may operate outside an OS environment by constructing for example a capsule file, passing the capsule file to firmware interface, and restarting the system. The firmware interface may load various drivers and applications contained within the capsule file and execute them to perform a task. Upon completion of the task, the OS is booted again and the original application may resume control, making use of any information stored by the firmware interface in a dedicated status table or file. Other embodiments may be employed, and other embodiments are described and claimed.12-31-2009

Ruth Lorberth, Berlin DE

Patent application numberDescriptionPublished
20100174061PLANTS WHICH SYNTHESIZE A MODIFIED STARCH, PROCESS FOR THE PRODUCTION THEREOF AND MODIFIED STARCH - Nucleic acid molecules are described encoding a starch granule-bound protein as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch with modified viscosity properties and a modified phosphate content. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.07-08-2010

Patent applications by Ruth Lorberth, Berlin DE

Ruth Männer, Oberpframmern DE

Patent application numberDescriptionPublished
20090102591Inductive Component and Method for Manufacturing an Inductive Component - A method for manufacturing an inductive component which is formed from a plurality of layers, wherein the method comprises the steps of a) arrangement of an electrically conductive material as a winding of the component on a first non-magnetic, dielectric ceramic layer; b) formation of at least one cutout which passes all the way through in the non-magnetic, dielectric ceramic layer; c) arrangement of a first magnetic ceramic layer on an upper face and a second magnetic ceramic layer on a lower face of the non-magnetic, dielectric ceramic layer; and d) carrying out a process step in which at least one of the magnetic ceramic layers is plastically deformed such that contact is made with the two magnetic ceramic layers in the area of the cutout, and the two magnetic ceramic layers form a magnetic core of the component.04-23-2009
20100014253Electronic Component Module and Method for Production Thereof - An electronic component module comprising at least one ceramic circuit carrier (01-21-2010
20100089620Electronic Component Module and Method for the Production Thereof - An electronic component module comprising: at least one multilayer ceramic circuit carrier (04-15-2010

Ruth Mckernan, Canterbury GB

Patent application numberDescriptionPublished
20120035207Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome - The invention provides a method of treating a condition selected from hearing disorders, vestibular disorders, attention disorders, intention tremor and restless leg syndrome comprising administering to a human patient in need thereof a therapeutically effective amount of a compound which is an agonist at GABA02-09-2012

Ruth Munoz Melgar, Madrid ES

Patent application numberDescriptionPublished
20080252051Knee Airbag - The present invention relates to an airbag intended for retaining the knees of the occupants of automotive vehicles during a collision consisting of an inflatable cushion (10-16-2008

Ruth Nussenzweig, New York, NY US

Patent application numberDescriptionPublished
20110182929MULTICOMPONENT VACCINE FOR MALARIA PROVIDING LONG-LASTING IMMUNE RESPONSES AGAINST PLASMODIA - Disclosed are immunogenic conjugates which elicit an immune response to 07-28-2011

Ruth Osovsky, Rehovot IL

Patent application numberDescriptionPublished
20110006285CORE-ALLOYED SHELL SEMICONDUCTOR NANOCRYSTALS - The invention relates to a core-alloyed shell semiconductor nanocrystal comprising: (i) a core of a semiconductor material having a selected band gap energy; (ii) a core-overcoating shell consisting of one or more layers comprised of an alloy of the said semiconductor of (i) and a second semiconductor; (iii) and an outer organic ligand layer, provided that the core semiconductor material is not HgTe. In certain embodiments, the core semiconductor material is PbSe and the alloy shell semiconductor material has the PbSe01-13-2011

Ruth Polachek, Rehovot IL

Patent application numberDescriptionPublished
20090292608Method and system for user interaction with advertisements sharing, rating of and interacting with online advertisements - A platform includes an overall system for user interaction, associated with a particular advertisement. The process enables users to interact with a widget directly associated with an advertisement and express themselves in regards to the advertisement. Advertisement displayed in the Internet or similar distributed computer network-based information distribution system. Such user interactions include engagement methods such as rating advertisements, sharing them with other users, commenting on them, and more. The platform can also include a host site, storing and processing data received by users. As well as means for targeting advertisements and serving them to users according to data collected through the platform directly inserted by the users or collected by the platform in regards to their interaction with the platform.11-26-2009

Ruth Schmid, Tille NO

Patent application numberDescriptionPublished
20090291506PROCESS - A process for the preparation of coated polymer particles containing superparamagnetic crystals, said process comprising reacting surface-functionalized, superparamagnetic crystal-containing polymer particles of diameter less than 0.5 μm with at least one polyisocyanate and at least one diol.11-26-2009

Ruth Smocha, San Francisco, CA US

Patent application numberDescriptionPublished
20110152465CARBONYL-ENE FUNCTIONALIZED POLYOLEFINS - Disclosed is a method for preparing a hydroxyl functionalized polymer from a Lewis acid promoted carbonyl-ene reaction comprising: selecting a vinylidene terminated polyolefin having a number average molecular weight from about 950 to about 5000 and having a terminal vinylidene content greater than 50 mole percent; selecting a carbonyl enophile; selecting a Lewis acid; and contacting the components in step a), b) and c) under reactive conditions to form the hydroxyl functionalized polymer.06-23-2011

Ruth Tenengauzer, Raanana IL

Patent application numberDescriptionPublished
20100120848STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM - The invention encompasses stable pharmaceutical compositions comprising montelukast or salts thereof and methods of preparing the same.05-13-2010

Patent applications by Ruth Tenengauzer, Raanana IL

Ruth Thieroff-Ekerdt, Mendham, NJ US

Patent application numberDescriptionPublished
20110003005Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions - Extended release ondansetron compositions of the present invention are useful for treating postoperative nausea and vomiting (PONV) and/or postdischarge nausea and vomiting (PDNV).01-06-2011
20110064799Pancreatic Enzyme Compositions and Methods for Treating Pancreatitis and Pancreatic Insufficiency - Compositions of the present invention, comprising the combination of enterically coated and uncoated pancreatic enzyme-containing beads are useful for treating or preventing pancreatitis pain, and optionally disorders associated with digestive enzyme deficiencies.03-17-2011

Ruth Timme, Avon, CT US

Patent application numberDescriptionPublished
20090200842WASHABLE CHILD CAR SEAT SUBFRAME - A child car seat subframe that is easily disassembled into component sections for washing within a residential-sized dishwasher. The car seat subframe can be disassembled by hand, and each individual component is cable of fitting in a residential-sized dishwasher individually and collectively. The component sections are attached by a combination of registration tabs and slots, and held tightly together by fasteners, or attached by a combination of tongue and groove joints. Hanging devices, such as hooks, may be formed on one side of each component section to facilitate hanging on racks in a dishwasher. The car seat subframe back panel and side panels are disassembled into a plurality of segments for easily fitting in a dishwasher.08-13-2009

Ruth Vandoren, Sint-Joris Winge BE

Patent application numberDescriptionPublished
20110289755ENGAGEMENT MEMBER WITH FASTENING PIN AND METHOD FOR INTERCONNECTING TWO COMPONENTS - The invention relates to an engagement member that is adapted to be fixed in a groove of a component and to a method for interconnecting two components via an engagement member. In order to provide an engagement member and a method, which provide for an easy assembly of the engagement member in the groove, whilst still providing sufficient forces for interconnecting the two components, the invention provides that the engagement member comprises a fastening pin that can be pushed into a cavity of one of the two components.12-01-2011
20110290953CABLE HOLDER AS WELL AS KIT AND CABLE MANAGEMENT SYSTEM COMPRISING THE SAME - The present invention relates to a cable holder for guiding a plurality of computer-network cables, including a loop with an inner circumference at least partially adapted to provide a support for the cables. The loop is formed of a first leg and a second leg extending essentially parallel to each other and being interconnected at a proximal end segment of each of the first and the second leg via a yoke, and a closure section, arranged at a distal end segment of each of the first and the second leg. The closure section includes at least one flap which is arranged at the distal end segment of the first or the second leg and extends towards the opposing distal end segment of the second or the first leg, respectively. Further, the invention relates to a kit and a cable management system comprising the cable holder. In order to easily add and remove a plurality of cables to and from the cable holder, respectively, the present invention provides that the at least one flap abuts the opposing distal end segment of the second or the first leg, respectively, in a resting position of the at least one flap, the at least one flap being adapted to be resiliently deflected from its resting position.12-01-2011

Ruth Wittmann-Price, Bethlehem, PA US

Patent application numberDescriptionPublished
20090260134SENSORY DEVELOPMENTAL CAP - A cap having ear pieces and an eyepiece. The ear pieces are preferably connected to an audio device that can play stored audio and/or rebroadcast ambient sounds at a reduced audio level. The ear pieces preferable provide sound attenuation of at least 20 dB. The stored audio may include sounds that simulate sounds heard by a fetus while in the womb. The eye piece is preferably removable.10-22-2009
20110091062SENSORY DEVELOPMENTAL CAP - A cap having ear pieces and an eyepiece. The ear pieces are preferably connected to an audio device that can play stored audio and/or rebroadcast ambient sounds at a reduced audio level. The ear pieces preferable provide sound attenuation of at least 20 dB. The stored audio may include sounds that simulate sounds heard by a fetus while in the womb. The eye piece is preferably removable.04-21-2011

Ruth Wittoek, Laame BE

Patent application numberDescriptionPublished
20110263948 SCORING SYSTEM TO MONITOR NATURAL OR DRUG-MODIFIED DISEASE PROGRESSION IN "EROSIVE OSTEOARTHRITIS" OF THE INTERPHALANGEAL FINGER JOINTS - The present invention provides a scoring system to monitor natural or drug-modified disease progression in erosive inter-phalangeal finger joint osteoarthrits and the use of said scoring system to identify and value drugs with anticatabolic and/or repair promoting potential.10-27-2011

Ruth Zajdman, Haifa IL

Patent application numberDescriptionPublished
20100292718FIXATING MEANS BETWEEN A MESH AND MESH DEPLOYMENT MEANS ESPECIALLY USEFUL FOR HERNIA REPAIR SURGERIES AND METHODS THEREOF - The present invention provides a fixating means (11-18-2010